Literature DB >> 27080942

Alpha-Actinin-4 is a Possible Target Protein for Aristolochic Acid I in Human Kidney Cells In Vitro.

Dan Wang1,2, Xiao-Wei Li1,2, Xuan Wang2, Huan-Ran Tan3, Yan Jia4, Li Yang4, Xiao-Mei Li4, Ming-Ying Shang1, Feng Xu1, Xing-Xin Yang1, Yukihiro Shoyama5, Shao-Qing Cai1.   

Abstract

Aristolochic acid I (AA-I) is a strong nephrotoxin, carcinogen, and mutagen found in plants such as the Aristolochia species. The mechanisms underlying AA-I toxicity in the kidneys are poorly understood. In this study, we aimed to gain insight into the mechanism of AA-I nephrotoxicity by analyzing the uptake, subcellular distribution, and intracellular targets of AA-I in the human kidney cell line HK-2 using immunocytochemistry, immunoprecipitation, and LC-MS/MS. In HK-2 cells incubated with 20[Formula: see text][Formula: see text]g/mL AA-I for different periods of time (up to 12[Formula: see text]h), AA-I was detected by a specific monoclonal antibody (MAb) against AA-I, both in the cytoplasm and nuclei. Nuclear localization depended on the exposure time. A protein with the molecular weight of 100 kDa was immunoprecipitated with the anti-AA-I MAb from the AA-I-treated cell lysates and was identified by LC-MS/MS as [Formula: see text]-actinin-4 after digestion of the protein, and was confirmed by immunoblotting with a specific anti-[Formula: see text]-actinin-4 MAb. This evidence shows, for the first time, that [Formula: see text]-actinin-4 is a protein targeted by AA-I in kidney cells. Our findings strongly suggest an association between [Formula: see text]-actinin-4 and AA-I nephrotoxic activity.

Entities:  

Keywords:  -Actinin-4; Aristolochic Acid; HK-2 Cells; IP-MS/MS; Immunocytochemistry; Immunoprecipitation (IP); Monoclonal Antibody

Mesh:

Substances:

Year:  2016        PMID: 27080942     DOI: 10.1142/S0192415X16500178

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

Review 1.  Immunological Separation of Bioactive Natural Compounds from Crude Drug Extract and Its Application for Cell-Based Studies.

Authors:  Takuhiro Uto; Tomoe Ohta; Shunsuke Fujii; Yukihiro Shoyama
Journal:  Antibodies (Basel)       Date:  2021-12-06

2.  Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.

Authors:  Cheng Fang; Juan-Juan Li; Tong Deng; Bing-Hui Li; Pei-Liang Geng; Xian-Tao Zeng
Journal:  Med Sci Monit       Date:  2019-05-04

3.  Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.

Authors:  Xigui Ma; Huiying Xue; Jixiang Zhong; Bo Feng; Yanghua Zuo
Journal:  Dis Markers       Date:  2020-08-14       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.